32P-postlabeling assay for the quantification of the major platinum- DNA adducts

Analytical Biochemistry

Volumn 275, Issue 1, 1999, Pages 30-38

  Pluim, Dick ^a   Maliepaard, Marc ^a   Van Waardenburg, Robert C A M ^a   Beijnen, Jos H ^a,b   Schellens, Jan H M ^a,b  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

32P postlabeling; Cisplatin; Intrastrand adduct; Platinum; White blood cells

Indexed keywords

CELL CULTURE; CELLS; DNA; EFFICIENCY; ION EXCHANGE; PLATINUM; SODIUM COMPOUNDS;

CIS-PLATIN; INTRASTRAND ADDUCT; LABELING EFFICIENCIES; LOWER LIMIT OF QUANTIFICATIONS; SCINTILLATION COUNTING; STRONG CATION EXCHANGE COLUMN; WHITE BLOOD CELLS; ^32P-POSTLABELING;

BLOOD;

ALCOHOL DERIVATIVE; CHLOROFORM; CISPLATIN; FORMIC ACID DERIVATIVE; PHENOL; PHOSPHORUS 32; PLATINUM; CISPLATIN DNA ADDUCT; CISPLATIN-DNA ADDUCT; DIAGNOSTIC AGENT; DNA; FORMIC ACID; PHOSPHORUS;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALIBRATION; CANCER; CATION EXCHANGE; CROSS LINKING; DNA ADDUCT; DRUG DNA BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; ISOTOPE LABELING; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ASSAY; SCINTILLATION COUNTING; ANIMAL; CHEMISTRY; METABOLISM; METHODOLOGY; NEOPLASM; NUDE MOUSE; REPRODUCIBILITY;

ANIMALIA;

ANIMALS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CISPLATIN; DNA; DNA ADDUCTS; FORMIC ACIDS; HUMANS; LEUKOCYTES; MICE; MICE, NUDE; NEOPLASMS; PHOSPHORUS RADIOISOTOPES; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS;

EID: 0033216633     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1006/abio.1999.4302     Document Type: Article

References (19)

1. Bruhn S. L., Toney J. H., Lippard S. J. Biological processing of DNA modified by platinum compounds. Prog. Inorg. Chem. Bioinorg. Chem. 38:1990;477-516.
2. Fichtinger-Schepman A. M. J., Van der Veer J. L., Den Hartog J. H. J., Lohman P. H. M., Reedijk J. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: Formation, identification and quantification. Biochemistry. 24:1985;707-713.
3. Eastman A. The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol. Ther. 34:1987;155-166.
4. Scovell W. M., Muirhead N., Kroos L. R. Cis-diamminedichloroplatinum(II) selectively cross-links high mobility group proteins 1 and 2 to DNA in micrococcal nuclease accessible regions of chromatin. Biochem. Biophys. Res. Commun. 142:1987;826-835.
5. Jones J. C., Zhen W., Reed E., Parker R. J., Sancar A., Bohr V. A. Gene specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese hamster ovary cells. J. Biol. Chem. 266:1991;7101-7107.
6. Banjar Z. M., Hnilica L. S., Briggs R. C., Stein J., Stein G. cis- and trans-Diamminedichloroplatinum(II)-mediated cross-linking of chromosomal non-histone proteins to DNA in HeLa cells. Biochemistry. 23:1984;1921-1926.
7. Hayes J. J., Scovell W. M. cis-Diamminedichloroplatinum(II) modified chromatin and nucleosomal core particle probed with DNAseI. Biochem. Biophys. Acta. 1088:1991;413-418.
8. Fichtinger-Schepman A. M. J., Welters M. J. P., Van Dijk-Knijnenburg H. C. M., Van der Sterre M. L. T, Tilby M. J., Berends F., Baan R. A. Pinedo H. M., Schornagel J. H. Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2. 1996;107-119 Plenum Press, New York.
9. Reed E., Sauerhoff S., Poirier M. C. Quantitation of platinum DNA binding after therapeutic levels of drug exposure. A novel use of graphite furnace spectrometry. Atom. Spectrosc. 9:1988;93-95.
10. Ma J., Verweij J., Kolker H. J., Van Ingen H. E., Stoter G., Schellens J. H. M. Pharmacokinetic-dynamic relationship of cisplatin in vitro: Simulation of an i.v. bolus and 3 h and 20 h infusion. Br. J. Cancer. 69:1994;858-862.
11. Fichtinger-Schepman A. M. J., Baan R. A., Luiten-Schuite A., Van Dijk M., Lohman P. H. M., Berend M. Immunochemical quantitation of adducts induced in DNA by cis-diamminedichloroplatinum(II) and analysis of adduct related DNA unwinding. Chem. Biol. Interactions. 55:1987;275-288.
12. Fichtinger-Schepman A. M. J., Van Oosterom A. T., Lohman P. H. M., Berends F. cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: Quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II). Cancer Res. 47:1987;3000-3004.
13. Sambrook J., Fritch E. F., Maniatis T. Molecular Cloning. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. p. 60-68.
14. Fichtinger-Schepman A. M. J., Van Dijk-Knijnenburg H. C. M., Dijt F. J., Van der Velde-Visser S. D., Berends F., Baan R. A. Effects of thiourea and ammonium bicarbonate on the formation and stability of bifunctional cisplatin-DNA adducts: Consequences for the accurate quantification of the adducts in (cellular) DNA. J. Inorg. Biochem. 58:1995;177-191.
15. 32P-postlabeling. Nucleic Acids Res. 23:1995;1300-1306.
16. 32P-postlabeling assay for the quantification of the major platinum-DNA adducts. Carcinogenesis. 18:1997;1767-1774.
17. Ma J., Verweij J., Planting A. S. T., de Boer-Dennert M., van Ingen H. E., van der Burg M. E. L., Stoter G., Schellens J. H. M. Current sample handling methods for measurement of platinum-DNA adducts in leukocytes in man lead to discrepant results in DNA adduct levels and DNA repair. Br. J. Cancer. 71:1995;512-517.
18. Schellens J. H. M., Ma J., Planting A. S. T., van der Burg M. E. L., van Meerten E., de Boer-Dennert M., Schmitz P. I. M., Stoter G., Verweij J. Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours. Br. J. Cancer. 73:1996;1569-1575.
19. Miller S. A., Dykes D. D., Polsky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215-1218.